ArticlePloS one2013
Level of unawareness and management of diabetes, hypertension, and dyslipidemia among adults in Luxembourg: findings from ORISCAV-LUX study.
Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The worldwide trend in diabetes awareness, treatment, and control from 1985 to 2022: a systematic review and meta-analysis of 233 population-representative studies.Frontiers in public health · 2024Pooled it
- Dyslipidemia in Lebanese children and adolescents: parents' knowledge and practices.BMC public health · 2026Article
- National trends in dyslipidemia prevalence, awareness, treatment, and control in South Korea from 2005 to 2022.Scientific reports · 2025Article
- National trends in dyslipidemia prevalence, awareness, treatment, and control in South Korea from 2005 to 2022.Scientific reports · 2025Article
- Observational
- Personality traits: an important factor affecting fear of movement in dialysis patients.Frontiers in psychiatry · 2025Article
- Awareness of Hypertension, Hypercholesterolemia, and Diabetes Mellitus and Associated Characteristics in Russian Adults.International journal of hypertension · 2024Article
- The Effect of Hypertension, Diabetes, and Hyperlipidemia on Medication Intake and Adherence: Analysis from Korean Health Panel Survey 2014-2017.Iranian journal of public health · 2023Article
- Awareness and Related Factors of Dyslipidemia in Menopausal Women in Korea.Healthcare (Basel, Switzerland) · 2022Article
- Towards precision cardiometabolic prevention: results from a machine learning, semi-supervised clustering approach in the nationwide population-based ORISCAV-LUX 2 study.Scientific reports · 2021Article
- Article
- Recognition and control of hypertension, diabetes, and dyslipidemia in patients with systemic lupus erythematosus.Clinical rheumatology · 2018Observational
- Recognition and control of hypertension, diabetes, and dyslipidemia in patients with rheumatoid arthritis.Rheumatology international · 2018Article
- Geographic Variations in Cardiometabolic Risk Factors in Luxembourg.International journal of environmental research and public health · 2017Article
- Socioeconomic Disparities in the Prevalence, Diagnosis, and Control of Hypertension in the Context of a Universal Health Insurance System.Journal of Korean medical science · 2017Article
- Six-year changes in the prevalence of obesity and obesity-related diseases in Northeastern China from 2007 to 2013.Scientific reports · 2017Article
- Parks and Green Areas Are Associated with Decreased Risk for Hyperlipidemia.International journal of environmental research and public health · 2016Article
- Hypertension burden in Luxembourg: Individual risk factors and geographic variations, 2013 to 2015 European Health Examination Survey.Medicine · 2016Article
- Hypertension and Diabetes Prevalence in Older Persons in Jamaica, 2012.The West Indian medical journal · 2014Article
- Dyslipidemia awareness, treatment, control and influence factors among adults in the Jilin province in China: a cross-sectional study.Lipids in health and disease · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn the absence of evidence-based information, assessment of population awareness and management of diabetes, hypertension and dyslipidemia (treatable and preventable cardiovascular risk factors) are important to halt coronary and cerebrovascular diseases and to improve public health.
methodsThe analysis was based on a nationally representative sample of 1432 adult subjects, recruited for the ORISCAV-LUX survey (2007-2008). Descriptive and multivariable logistic regression analyses were performed. The 10-year Framingham risk score was calculated for each participant who classified at low, intermediate and high risk.
resultsAmong the diagnosed cases, 32%, 60%, and 85% were respectively unaware of their diabetes, hypertension and dyslipidemia. Increasing age and BMI were the strongest protective factors against unawareness of hypertension and dyslipidemia. Having a family history decreased the risk of unawareness of hypertension (OR = 0.57; 95% CI 0.36, 0.92; P = 0.021), whereas, not having a family doctor increased double-fold the odd of being unaware of hypertension (P = 0.048). Poor health perception reduced significantly the risk of unawareness of dyslipidemia (OR = 0.27; 95% CI 0.11, 0.68). Concerning the management, diabetes was markedly better treated than hypertension and dyslipidemia. Among diabetic subjects (constituting 4% of the population), 3% were treated vs. 1% not treated. In contrast, 22% of the hypertensive participants (35% of the population) were not treated vs. 13% treated. Concerning dyslipidemia, only 9% of those with lipid disorder (70% of the population) were under medication vs. 61% not treated. For the treated cases of these pathologies, almost only one-third was under control. Framingham risk of developing CHD within 10 years was moderate to high among 62%, 27%, and 17% of the unaware/untreated diabetic, hypertensive, and dyslipidemic participants, respectively.
conclusionThe considerable lack of awareness and insufficient management underscore the urgent need for intensive efforts to reduce the gap in prevention strategies, and control of cases according to explicit clinical guidelines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.